Supplemental Annuity Collective Trust Of Nj Viking Therapeutics, Inc. Transaction History
Supplemental Annuity Collective Trust Of Nj
- $320 Million
- Q2 2024
A detailed history of Supplemental Annuity Collective Trust Of Nj transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Supplemental Annuity Collective Trust Of Nj holds 7,000 shares of VKTX stock, worth $431,410. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,000Holding current value
$431,410% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$371 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$316 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$139 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$115 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.73B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...